A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a randomized, double‐blind, placebo‐controlled Phase 2A study to evaluate safety, efficacy, PK, and dose response of oral CIN‐102 in adults with idiopathic and diabetic gastroparesis. The study will assess three oral doses of CIN‐102 versus placebo in three separate cohorts.
Epistemonikos ID: f0200d9f4b468c28aa425a1af0f4708a8ef46dd5
First added on: May 22, 2024